List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #52,941 to #52,990.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. The Living Guidelines: STEMI PCI after Successful Fibrinolysis or for Patients not Undergoing Primary Reperfusion View the Current CLASS IIb Guidelines → ST elevation myocardial infarction percutaneous coronary intervention following fibrinolytic administration
  2. The Living Guidelines: STEMI Recommendations ACE Inhibitors Therapy View the Current CLASS I Guidelines → ST elevation myocardial infarction inhibition of the renin-angiotensin-aldosterone system at discharge
  3. The Living Guidelines: STEMI Recommendations for ACE Inhibitors Therapy View the Current CLASS IIa Guidelines → ST elevation myocardial infarction inhibition of the renin-angiotensin-aldosterone system at discharge
  4. The Living Guidelines: STEMI Recommendations for Additional Management Considerations for Beta Blocker Therapy View the Current CLASS I Guidelines → ST elevation myocardial infarction beta blocker therapy
  5. The Living Guidelines: STEMI Recommendations for Aldosterone Blockers Therapy View the Current CLASS I Guidelines → ST elevation myocardial infarction inhibition of the renin-angiotensin-aldosterone system at discharge
  6. The Living Guidelines: STEMI Recommendations for Angiotensin Receptor Blockers Therapy View the Current CLASS IIb Guidelines → ST elevation myocardial infarction inhibition of the renin-angiotensin-aldosterone system at discharge
  7. The Living Guidelines: STEMI Recommendations for Angiotensin Receptor Blockers Therapy View the Current CLASS I Guidelines → ST elevation myocardial infarction inhibition of the renin-angiotensin-aldosterone system at discharge
  8. The Living Guidelines: STEMI Recommendations for Beta Blocker Therapy View the Current CLASS III Guidelines → ST elevation myocardial infarction beta blocker therapy
  9. The Living Guidelines: STEMI Recommendations for Beta Blocker Therapy View the Current CLASS IIa Guidelines → ST elevation myocardial infarction beta blocker therapy
  10. The Living Guidelines: STEMI Recommendations for Inhibition of the Renin-Angiotensin-Aldosterone System View the Current CLASS IIa Guidelines → ST elevation myocardial infarction secondary prevention
  11. The Living Guidelines: STEMI Recommendations for Inhibition of the Renin-Angiotensin-Aldosterone System View the Current CLASS IIb Guidelines → ST elevation myocardial infarction secondary prevention
  12. The Living Guidelines: STEMI Recommendations for Inhibition of the Renin-Angiotensin-Aldosterone System View the Current CLASS I Guidelines → ST elevation myocardial infarction secondary prevention
  13. The Living Guidelines: STEMI Reperfusion View the Current CLASS I Guidelines → ST elevation myocardial infarction reperfusion therapy
  14. The Living Guidelines: STEMI Thienopyridines View the Current CLASS IIa Guidelines → ST elevation myocardial infarction thienopyridine therapy
  15. The Living Guidelines: STEMI Thienopyridines View the Current CLASS I Guidelines → ST elevation myocardial infarction thienopyridine therapy
  16. The Living Guidelines: Serial Clinical Assessment of Patients Presenting with Heart Failure. View the Current CLASS IIa Guidelines → Congestive heart failure clinical assessment
  17. The Living Guidelines: Serial Clinical Assessment of Patients Presenting with Heart Failure. View the Current CLASS IIb Guidelines → Congestive heart failure clinical assessment
  18. The Living Guidelines: Serial Clinical Assessment of Patients Presenting with Heart Failure. View the Current CLASS I Guidelines → Congestive heart failure clinical assessment
  19. The Living Guidelines: Treatment of Special Populations. View the Current CLASS IIa Guidelines → Congestive heart failure treatment of special populations
  20. The Living Guidelines: Treatment of Special Populations. View the Current CLASS I Guidelines → Congestive heart failure treatment of special populations
  21. The Living Guidelines: UA/NSTEMI Anticoagulant Therapy View the Current CLASS IIa Guidelines → Unstable angina / non ST elevation myocardial infarction anticoagulant therapy#ACC / AHA Guidelines (DO NOT EDIT)
  22. The Living Guidelines: UA/NSTEMI Anticoagulant Therapy View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction anticoagulant therapy#ACC / AHA Guidelines (DO NOT EDIT)
  23. The Living Guidelines: UA/NSTEMI Antiplatelet Therapy View the Current CLASS III Guidelines → Unstable angina / non ST elevation myocardial infarction antiplatelet therapy#ACC / AHA Guidelines (DO NOT EDIT)
  24. The Living Guidelines: UA/NSTEMI Antiplatelet Therapy View the Current CLASS IIa Guidelines → Unstable angina / non ST elevation myocardial infarction antiplatelet therapy#ACC / AHA Guidelines (DO NOT EDIT)
  25. The Living Guidelines: UA/NSTEMI Antiplatelet Therapy View the Current CLASS IIb Guidelines → Unstable angina / non ST elevation myocardial infarction antiplatelet therapy#ACC / AHA Guidelines (DO NOT EDIT)
  26. The Living Guidelines: UA/NSTEMI Antiplatelet Therapy View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction antiplatelet therapy#ACC / AHA Guidelines (DO NOT EDIT)
  27. The Living Guidelines: UA/NSTEMI Recomendations for Additional Management Considerations for Antiplatelet and Anticoagulant Therapy View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction additional management considerations for antiplatelet and anticoagulant therapy#ACC / AHA Guidelines (DO NOT EDIT)
  28. The Living Guidelines: UA/NSTEMI Recommendations for Additional Management Considerations for Antiplatelet and Anticoagulant Therapy View the Current CLASS III Guidelines → Unstable angina / non ST elevation myocardial infarction additional management considerations for antiplatelet and anticoagulant therapy#ACC / AHA Guidelines (DO NOT EDIT)
  29. The Living Guidelines: UA/NSTEMI Recommendations for Additional Management Considerations for Antiplatelet and Anticoagulant Therapy View the Current CLASS IIa Guidelines → Unstable angina / non ST elevation myocardial infarction additional management considerations for antiplatelet and anticoagulant therapy#ACC / AHA Guidelines (DO NOT EDIT)
  30. The Living Guidelines: UA/NSTEMI Recommendations for Additional Management Considerations for Antiplatelet and Anticoagulant Therapy View the Current CLASS IIb Guidelines → Unstable angina / non ST elevation myocardial infarction additional management considerations for antiplatelet and anticoagulant therapy#ACC / AHA Guidelines (DO NOT EDIT)
  31. The Living Guidelines: UA/NSTEMI Recommendations for Anti Ischemic Therapy View the Current CLASS III Guidelines → Unstable angina / non ST elevation myocardial infarction initial therapy
  32. The Living Guidelines: UA/NSTEMI Recommendations for Anti Ischemic Therapy View the Current CLASS IIa Guidelines → Unstable angina / non ST elevation myocardial infarction initial therapy
  33. The Living Guidelines: UA/NSTEMI Recommendations for Anti Ischemic Therapy View the Current CLASS IIb Guidelines → Unstable angina / non ST elevation myocardial infarction initial therapy
  34. The Living Guidelines: UA/NSTEMI Recommendations for Anti Ischemic Therapy View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction initial therapy
  35. The Living Guidelines: UA/NSTEMI Recommendations for Antioxidant Vitamins and Folic Acid Use View the Current CLASS III Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention
  36. The Living Guidelines: UA/NSTEMI Recommendations for Beta Blockers Therapy View the Current CLASS IIa Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention
  37. The Living Guidelines: UA/NSTEMI Recommendations for Beta Blockers Therapy View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention
  38. The Living Guidelines: UA/NSTEMI Recommendations for Blood Pressure Control View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention
  39. The Living Guidelines: UA/NSTEMI Recommendations for CABG View the Current CLASS III Guidelines → Unstable angina / non ST elevation myocardial infarction recommendations for CABG#ACC / AHA Guidelines (DO NOT EDIT)
  40. The Living Guidelines: UA/NSTEMI Recommendations for CABG View the Current CLASS IIa Guidelines → Unstable angina / non ST elevation myocardial infarction recommendations for CABG#ACC / AHA Guidelines (DO NOT EDIT)
  41. The Living Guidelines: UA/NSTEMI Recommendations for CABG View the Current CLASS IIb Guidelines → Unstable angina / non ST elevation myocardial infarction recommendations for CABG#ACC / AHA Guidelines (DO NOT EDIT)
  42. The Living Guidelines: UA/NSTEMI Recommendations for CABG View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction recommendations for CABG#ACC / AHA Guidelines (DO NOT EDIT)
  43. The Living Guidelines: UA/NSTEMI Recommendations for Calcium Channel Blockers Therapy View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention
  44. The Living Guidelines: UA/NSTEMI Recommendations for Cardiac Rehabilitation View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction cardiac rehabilitation#ACC / AHA Guidelines (DO NOT EDIT)
  45. The Living Guidelines: UA/NSTEMI Recommendations for Depression View the Current CLASS IIa Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention
  46. The Living Guidelines: UA/NSTEMI Recommendations for Diabetes Mellitus Management View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention
  47. The Living Guidelines: UA/NSTEMI Recommendations for Early Risk Stratification View the Current CLASS III Guidelines → Unstable angina / non ST elevation myocardial infarction risk stratification and prognosis
  48. The Living Guidelines: UA/NSTEMI Recommendations for Early Risk Stratification View the Current CLASS IIa Guidelines → Unstable angina / non ST elevation myocardial infarction risk stratification and prognosis
  49. The Living Guidelines: UA/NSTEMI Recommendations for Early Risk Stratification View the Current CLASS IIb Guidelines → Unstable angina / non ST elevation myocardial infarction risk stratification and prognosis
  50. The Living Guidelines: UA/NSTEMI Recommendations for Early Risk Stratification View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction risk stratification and prognosis

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:ListRedirects"